Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Human intravenous immunoglobulin therapy benefits, prescription and interventions to cost management.
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Poster
- By: HADAD, Salim (Rambam - health care campus, Haifa, Israel)
- Co-author(s): Pollak, Shimon (Rambam - health care campus, HAIFA, Israel)
Krivoy, Norberto (Rambam - health care campus, HAIFA, Israel) - Abstract:
Department of Pharmacy Services, department of administration and immunology institute, Clinical Pharmacology institute. Rambam Health Care Campus and Rappaport Facullty of Medicine,Technion-Israel Institute of Technology, Haifa, Isreal.
In Israel according to MOH registration, the intravenous Immunoglobulin-IVIG- therapy has the following.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 October 2019